DOJ Backs AbbVie At 7th Circ. In 'Patent Thicket' Case
The U.S. Department of Justice has thrown its weight behind AbbVie at the Seventh Circuit as Humira buyers look to revive their suit accusing the drugmaker of employing a "patent thicket"...To view the full article, register now.
Already a subscriber? Click here to view full article